Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease

被引:99
作者
Fan, Zhen [1 ]
Okello, Aren A. [1 ]
Brooks, David J. [1 ,2 ]
Edison, Paul [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neurol Imaging Unit, London W12 0NN, England
[2] Aarhus Univ, Dept Nucl Med, DK-8000 Aarhus C, Denmark
基金
英国医学研究理事会;
关键词
Alzheimer's disease; microglia; amyloid imaging; neuropathology; dementia; VIVO RADIOLIGAND BINDING; FDG-PET; PARKINSONS-DISEASE; INFLAMMATION; BRAIN; HYPOMETABOLISM; RECEPTOR; PROTEIN; CLASSIFICATION; BIOMARKER;
D O I
10.1093/brain/awv288
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyloid deposition, tangle formation, neuroinflammation and neuronal dysfunction are pathological processes involved in Alzheimer's disease. However, the relative role of these processes in driving disease progression is still unclear. The aim of this positron emission tomography study was to: (i) investigate longitudinal changes of microglial activation, amyloid and glucose metabolism; and (ii) assess the temporospatial relationship between these three processes in Alzheimer's disease. A group of eight patients with a diagnosis of Alzheimer's disease (66 +/- 4.8 years) and 14 healthy controls (65 +/- 5.5 years) underwent T-1 and T-2 magnetic resonance imaging, along with C-11-(R)-PK11195, C-11-Pittsburgh compound B and F-18-fluorodeoxyglucose positron emission tomography scans for microglial activation, amyloid deposition and glucose metabolism. All patients were followed-up with repeated magnetic resonance imaging and three positron emission tomography scans after 16 months. Parametric maps were interrogated using region of interest analysis, Statistical Parametric Mapping, and between-group correlation analysis at voxel-level using Biological Parametric Mapping. At baseline, patients with Alzheimer's disease showed significantly increased microglial activation compared to the control subjects. During follow-up, for the first time, we found that while there is a progressive reduction of glucose metabolism, there was a longitudinal increase of microglial activation in the majority of the patients with Alzheimer's disease. Voxel-wise correlation analysis revealed that microglial activation in patients with Alzheimer's disease was positively correlated with amyloid deposition and inversely correlated with regional cerebral metabolic rate at voxel level over time. Even though one of the limitations of this study is the lack of longitudinal follow-up of healthy control subjects, this study demonstrates that there is persistent neuroinflammation throughout the Alzheimer's disease process with associated synaptic dysfunction and reduced glucose metabolism. Voxel-wise correlation analysis suggests that neuroinflammation is associated with localized amyloid deposition and glucose metabolism over time, however, the level of inflammation could also occur independently of amyloid pathology, especially in the later stages of Alzheimer's disease.
引用
收藏
页码:3685 / 3698
页数:14
相关论文
共 50 条
[1]   Cell mediators of inflammation in the Alzheimer disease brain [J].
Akiyama, H ;
Arai, T ;
Kondo, H ;
Tanno, E ;
Haga, C ;
Ikeda, K .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 :S47-S53
[2]   Inflammation in neurodegenerative diseases [J].
Amor, Sandra ;
Puentes, Fabiola ;
Baker, David ;
van der Valk, Paul .
IMMUNOLOGY, 2010, 129 (02) :154-169
[3]   A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195 [J].
Anderson, Alexander N. ;
Pavese, Nicola ;
Edison, Paul ;
Tai, Yan F. ;
Hammers, Alexander ;
Gerhard, Alexander ;
Brooks, David J. ;
Turkheimer, Federico E. .
NEUROIMAGE, 2007, 36 (01) :28-37
[4]   Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E [J].
Barger, SW ;
Harmon, AD .
NATURE, 1997, 388 (6645) :878-881
[5]   How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes [J].
Blasko, I ;
Stampfer-Kountchev, M ;
Robatscher, P ;
Veerhuis, R ;
Eikelenboom, P ;
Grubeck-Loebenstein, B .
AGING CELL, 2004, 3 (04) :169-176
[6]   Microglia-mediated neurotoxicity: uncovering the molecular mechanisms [J].
Block, Michelle L. ;
Zecca, Luigi ;
Hong, Jau-Shyong .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (01) :57-69
[7]  
Brix G, 1997, J NUCL MED, V38, P1614
[8]  
Chételat G, 2013, NAT REV NEUROL, V9, P123, DOI [10.1038/nrneurol.2013.21, 10.1038/nrneurol.2013.21-c2]
[9]   MICROGLIA AND CYTOKINES IN NEUROLOGICAL DISEASE, WITH SPECIAL REFERENCE TO AIDS AND ALZHEIMERS-DISEASE [J].
DICKSON, DW ;
LEE, SC ;
MATTIACE, LA ;
YEN, SHC ;
BROSNAN, C .
GLIA, 1993, 7 (01) :75-83
[10]   Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia [J].
Edison, Paul ;
Ahmed, Imtiaz ;
Fan, Zhen ;
Hinz, Rainer ;
Gelosa, Giorgio ;
Chaudhuri, K. Ray ;
Walker, Zuzana ;
Turkheimer, Federico E. ;
Brooks, David J. .
NEUROPSYCHOPHARMACOLOGY, 2013, 38 (06) :938-949